Amphastar Pharmaceuticals AMPH
NASDAQ AMPH
$25.23 -0.13 (-0.49%)
As of: Oct 2, 2026 · 11:41 AM EDT

Amphastar Pharmaceuticals (AMPH) Selling, General & Administrative (2013 - 2026)

Updated

Amphastar Pharmaceuticals' Selling, General & Administrative was $18.24 million in Q2 2026, up 30.4% from $13.99 million a year earlier and up 1.2% from the prior quarter.

Analysis

Amphastar Pharmaceuticals (AMPH) Selling, General & Administrative (2013 - 2026) Analysis & Trends

On a trailing twelve-month basis, Amphastar Pharmaceuticals' Selling, General & Administrative was $92.21 million through Jun 30, 2026, up 59.7% year-over-year; for FY2025, it was $85.93 million, up 51.5% from FY2024.

  • Selling, General & Administrative has now increased for three consecutive years, with a five-year compound annual growth rate of 11.3% (FY2020 to FY2025).
  • In earlier years, Selling, General & Administrative was $56.72 million in FY2024 (+10.1%), $51.54 million in FY2023 (+14.4%), $45.06 million in FY2022 (-12.4%) and $51.43 million in FY2021 (+2.1%).
  • Quarterly Selling, General & Administrative has moved between $9.98 million (Q2 2022) and $39.47 million (Q3 2025) over five years.
  • Compared with a year earlier, Selling, General & Administrative has increased for six straight quarters, with growth averaging 32.5% over the last eight quarters.
  • The best year-over-year quarter for Selling, General & Administrative over five years was Q3 2025 (growth of 166.3%); the worst was Q2 2022 (a decline of 31.5%).
  • Per Business Quant data, AMPH's Selling, General & Administrative in the three quarters before Q2 2026 was $18.03 million (Q1 2026), $16.47 million (Q4 2025) and $39.47 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 6.43 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 3.63 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.90 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -3.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -5.65 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.75 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 1.92 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 3.41 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 582.20 Mn
10 Amphastar Pharmaceuticals 1.10 Bn -43.34 Mn 93.47 Mn 18.24 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 18.24 Mn
Mar 31, 2026 18.03 Mn
Dec 31, 2025 16.47 Mn
Sep 30, 2025 39.47 Mn
Jun 30, 2025 13.99 Mn
Mar 31, 2025 16.00 Mn
Dec 31, 2024 12.94 Mn
Sep 30, 2024 14.82 Mn
Jun 30, 2024 13.29 Mn
Mar 31, 2024 15.68 Mn
Dec 31, 2023 13.12 Mn
Sep 30, 2023 12.65 Mn
Jun 30, 2023 12.28 Mn
Mar 31, 2023 13.48 Mn
Dec 31, 2022 10.63 Mn
Sep 30, 2022 11.98 Mn
Jun 30, 2022 9.98 Mn
Mar 31, 2022 12.47 Mn
Dec 31, 2021 10.62 Mn
Sep 30, 2021 10.91 Mn
API Access

Amphastar Pharmaceuticals Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=AMPH&period=max&api_key=YOUR_API_KEY